SHI Zaixiang's experience in using Shengxian SanjiaFumai Decoction to treat palpitation and chest obstruction in patients with long COVID-19 syndrome

CUI Hailan; GAO Wei; ZHU Tingting; SHI Zaixiang

doi:10.16025/j.1674-1307.2024.03.012

您当前的位置：

首页 >

文章列表页 >

SHI Zaixiang's experience in using Shengxian SanjiaFumai Decoction to treat palpitation and chest obstruction in patients with long COVID-19 syndrome

更新时间：2024-04-30

- SHI Zaixiang's experience in using Shengxian SanjiaFumai Decoction to treat palpitation and chest obstruction in patients with long COVID-19 syndrome
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 3, Pages: 283-285(2024)
- 作者机构：
  
  1.北京市昌平区中医医院肾病科，北京 102200
  2.北京市朝阳区八里庄社区卫生服务中心中医科，北京 100025
  3.北京市第六医院中医科，北京 100007
  4.中日友好医院中西医结合心内科，北京 100029
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.03.012
  CLC：
- Published：25 March 2024，
  
  Received：29 July 2023，
扫描看全文
崔海兰，高伟，朱婷婷，等.史载祥运用升陷三甲复脉汤治疗长新冠心悸胸闷经验［J］.北京中医药，2024，43（3）：283-285.

CUI Hailan,GAO Wei,ZHU Tingting,et al.SHI Zaixiang's experience in using Shengxian SanjiaFumai Decoction to treat palpitation and chest obstruction in patients with long COVID-19 syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(03):283-285.
崔海兰，高伟，朱婷婷，等.史载祥运用升陷三甲复脉汤治疗长新冠心悸胸闷经验［J］.北京中医药，2024，43（3）：283-285. DOI： 10.16025/j.1674-1307.2024.03.012.

CUI Hailan,GAO Wei,ZHU Tingting,et al.SHI Zaixiang's experience in using Shengxian SanjiaFumai Decoction to treat palpitation and chest obstruction in patients with long COVID-19 syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(03):283-285. DOI： 10.16025/j.1674-1307.2024.03.012.

摘要

长新冠综合征是感染新型冠状病毒后出现的长期症状，其中以心悸、胸闷为主症的患者较为多见。史载祥教授认为新型冠状病毒感染属中医学“疫病”范畴，其临床表现符合温病的发病及传变规律，因此对于长新冠人群应参照温病后期的调摄原则，在临床治疗中应重视固护人体气阴及恢复气机升降出入。根据长新冠人群心悸、胸闷为主症的证候特点，史载祥教授将其核心病机总结为疫毒之邪耗气伤阴、久病入络，所致大气下陷、气阴两虚、血瘀络阻，运用升陷三甲复脉汤加减施治此类病症疗效显著。

Abstract

关键词

长新冠新型冠状病毒心悸胸闷升陷三甲复脉汤史载祥名医经验

Keywords

references

SORIANO JB, MURTHY S, MARSHALL JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus[J]. Lancet Infect Dis, 2022,22(4):e102-e107.

SOLLINI M, MORBELLI S, CICCARELLI M, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study[J]. Eur J Nucl Med Mol Imaging, 2021,48(10):3187-3197.

KOROMPOKI E, GAVRIATOPOULOU M, HICKLEN RS, et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review[J]. J Infect, 2021,83(1):1-16.

LU Y, LI X, GENG D, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study[J]. EClinicalMedicine, 2020,25:100484.

张睿,国丽群,刘香弟,等.新型冠状病毒肺炎患者出院后康复现况调查[J].北京中医药,2021,40(8):918-920.

DAVIS HE,ASSAF GS,MCCORKELL L, et al. Characterizing long COVID in an international cohort:7 months of symptoms and their impact[J]. E Clin Med,2021,38:101019.

HUANG L, YAO Q, GU X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study[J]. Lancet, 2021,398(10302):747-758.

朱君瑶, 史忠亮, 古惠文,等. 史载祥教授辨治心衰病气陷血瘀证临床经验[J]. 中西医结合心脑血管病杂志,2020,18(22):3894-3896.

卢海宁, 张展林, 史忠亮,等. 史载祥教授运用升陷祛瘀法治疗心律失常经验拾萃[J]. 时珍国医国药,2019,30(3):709-711.

毛凯凤, 尹鑫, 左天,等. 史载祥教授升陷祛瘀汤加减治疗高血压病气陷血瘀证经验[J]. 中国中西医结合杂志,2018,38(5):628-629.

陈辉,史载祥.病毒性心肌炎伴二度Ⅰ型房室传导阻滞验案1则[J].北京中医药,2018,37(3):280-281.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Experience of Li Yi in prevention and treatment of Omicron variant of the new crown virus with harmony concept

DONG Zhenhua's experience in treating systemic sclerosis

QI Bao-yu's clinical experience in using the method for promoting blood circulation and removing blood stasis to treat diseases related to retinal blood syndrome

LI Qian-gou's clinical experience in treating throat Bi disease from the perspective of liver and spleen

ZHANG Bing-hou's experience in applying prescriptions of Zisheng Qingyang Decoction

Related Author

WANG Bao

LI Yi

YANG mei

LIU wei

DONG Zhen-hua

SUN Wan-yu

ZHANG Xiu-qing

PEI Zheng

Related Institution

北京医院中医科国家老年医学中心中国医学科学院老年医学研究院

北京协和医院中医科

北京市和平里医院针灸科

北京中医药大学东方医院眼科

中国中医科学院眼科医院眼功能检查科

⁰